Study record

Exercise and Metabolic Health: The Emerging Roles of Novel Exerkines

Türkel İ, Özerkliğ B, Atakan MM et al. · Curr Protein Pept Sci · 2022

ReviewEndogenous MOTS-c measuredEvidence tier R

What this study reported

Reviewed exercise-induced molecules, listing MOTS-c alongside BDNF, miR-1, 12,13-diHOME, irisin, SPX, osteocalcin, GDF15 and FGF21, and summarised reported relationships with obesity, insulin resistance and type 2 diabetes. MOTS-c is mentioned as one item in a broader exerkine summary rather than examined in detail.

Limitations

Broad narrative review with no systematic search; MOTS-c receives only brief coverage among many molecules, and no primary data are presented.

Study record

Annotated fields for this study
Study modelReview
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
SpeciesNot reported
System studiedNarrative review of exercise-induced signalling molecules (exerkines) from muscle, adipose tissue, bone and liver
PopulationNot reported
DesignNarrative review
Sample size as reportedNot reported
Control groupNot reported
Route (data field only)Not reported
Endpoints measuredreported exerkine effects on obesity; insulin resistance; type 2 diabetes
Pathways measuredInsulin & glucose handling
Research areasExercise · Metabolic
Evidence tierR — Review (context, not evidence)
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Peripheral
Model applicability
n/a
Sample size
n/a
Controls
n/a
Outcome validity
n/a
Support for its own conclusion
Weak

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.